47 related articles for article (PubMed ID: 38582693)
1. Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling study.
Oh H; Tan C; Williams C; Giannelos N; Ng C
Hum Vaccin Immunother; 2024 Dec; 20(1):2348839. PubMed ID: 38804600
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study.
Desai A; Hashash JG; Kochhar GS; Hayney MS; Caldera F; Farraye FA
J Crohns Colitis; 2024 Jun; 18(6):828-835. PubMed ID: 38224526
[TBL] [Abstract][Full Text] [Related]
3. The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain.
García A; Vallejo-Aparicio LA; Cambronero Martinez R
Hum Vaccin Immunother; 2024 Dec; 20(1):2366353. PubMed ID: 38925145
[TBL] [Abstract][Full Text] [Related]
4. Herpes zoster in Belgium: a new solution to an old problem.
Nikkels AF; Schoevaerdts D; Kauffmann F; Strubbe F; Bensemmane S
Acta Clin Belg; 2024 May; ():1-12. PubMed ID: 38781037
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression.
Losa L; Antonazzo IC; Di Martino G; Mazzaglia G; Tafuri S; Mantovani LG; Ferrara P
Vaccines (Basel); 2024 May; 12(5):. PubMed ID: 38793778
[TBL] [Abstract][Full Text] [Related]
6. Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older.
George S; Carrico J; Hicks KA; Loukov D; Ng C; Regan J; Giannelos N
Pharmacoecon Open; 2024 May; 8(3):481-492. PubMed ID: 38605257
[TBL] [Abstract][Full Text] [Related]
7. Increased Risk of Herpes Zoster Infection in Patients with Celiac Disease 50 Years Old and Older.
Chatterjee A; Chittajallu V; Ford A; Alchirazi KA; Nanah R; Mansoor E; DeLozier S; Jansson-Knodell C; Rubio-Tapia A
Dig Dis Sci; 2024 May; ():. PubMed ID: 38816598
[TBL] [Abstract][Full Text] [Related]
8. Herpes zoster in the context of immune reconstitution inflammatory syndrome in patients with rheumatic diseases: a single-center retrospective study.
Maeshima K
Immunol Med; 2024 Jun; ():1-7. PubMed ID: 38940440
[TBL] [Abstract][Full Text] [Related]
9. Zoster vaccine lowers stroke and myocardial infarction risk in chronic disease.
Helm MF; Khoury PA; Warne M; Maczuga S; Chinchilli VM; Butt M; Morawo A; Foulke GT
Am J Prev Med; 2024 Jun; ():. PubMed ID: 38909663
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum to "Chronic respiratory diseases as a risk factor for herpes zoster infection" [Arch Bronconeumol. 2024;59(12):797-804].
Morena D; Lumbreras S; Rodríguez JM; Campos C; Castillo M; Benavent M; Izquierdo JL
Arch Bronconeumol; 2024 May; ():. PubMed ID: 38849273
[No Abstract] [Full Text] [Related]
11. Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial.
Alexandra Echeverria Proano D; Zhu F; Sun X; Zoco J; Soni J; Parmar N; Ali SO;
Hum Vaccin Immunother; 2024 Dec; 20(1):2351584. PubMed ID: 38838170
[TBL] [Abstract][Full Text] [Related]
12. A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations.
Parikh R; Widenmaier R; Lecrenier N
Expert Rev Vaccines; 2021 Sep; 20(9):1065-1075. PubMed ID: 34311643
[TBL] [Abstract][Full Text] [Related]
13. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
Pirrotta P; Tavares-Da-Silva F; Co M; Lecrenier N; Hervé C; Stegmann JU
Drug Saf; 2021 Dec; 44(12):1341-1353. PubMed ID: 34622421
[TBL] [Abstract][Full Text] [Related]
14. Vaccines for preventing herpes zoster in older adults.
de Oliveira Gomes J; Gagliardi AM; Andriolo BN; Torloni MR; Andriolo RB; Puga MEDS; Canteiro Cruz E
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD008858. PubMed ID: 37781954
[TBL] [Abstract][Full Text] [Related]
15. Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021-23.
Stefanizzi P; Moscara L; Palmieri C; Martinelli A; Di Lorenzo A; Venerito V; Germinario CA; Tafuri S
Vaccine; 2024 Apr; 42(12):2966-2974. PubMed ID: 38582693
[TBL] [Abstract][Full Text] [Related]
16. Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials.
López-Fauqued M; Co-van der Mee M; Bastidas A; Beukelaers P; Dagnew AF; Fernandez Garcia JJ; Schuind A; Tavares-da-Silva F
Drug Saf; 2021 Jul; 44(7):811-823. PubMed ID: 34115324
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
